Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Vaccine
DNA vaccine inhibits breast cancer in mice through induction of autoimmunity
April 7th, 2005
Xenogeneic DNA vaccination inhibits mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity. According to a study from Italy, "Plasmid DNA vectors encoding the full-length (VR1012/HER-2-FL) or only the extracellular and transmembrane domains (VR1012/HER-2-ECD-TM) of human (h) HER-2/neu protooncogene were used to vaccinate HER-2/neu transgenic mice (N202) engineered to overexpress the rat (r) neu protooncogene product (r-p185neu). Both the full-length and the deleted vaccines were significantly (p=0.0001 and p=0.06, respectively) more active than the empty-vector (VR1012/EV) in preventing and delaying HER-2/neu-driven...
Source: Women's Health Weekly (2005-04-07)
|